Dr Tony Keating, CEO/MD of ResApp Health (ASX:RAP) explains the current trends in COVID-19 testing, in particular the differences between PCR (Polymerase Chain Reaction) and RAT (Rapid Antigen Testing). He also goes into detail about ResApp’s development of an ‘instant’ screening test for COVID-19 using only a smartphone and how this tool will revolutionise the way the world will live with COVID.
